HMGA1 and cholangiocarcinoma: It has been established that in CCA, HMGA1 is a commonly overexpressed [2, 10] ; however, the regulatory mechanism of HMGA1 and the clinical treatment strategies targeting HMGA1 overexpression remain unclear.